KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy

Authors:

Abstract
No abstract available
Funding Information
  • Key Technologies Research and Development Program (2021YFA1300601)
  • Shanghai Rising-Star Program (24QA2710000)
  • National Natural Science Foundation of China
  • National Natural Science Foundation of China National Outstanding Youth Science Fund Project (82425103, 82341012, 82203495, 82372771, 81825018, 82130085)
  • National Key Research and Development Program of China
  • Youth Innovation Promotion Association of the Chinese Academy of Sciences
  • Chinese Academy of Sciences

This publication has 92 references indexed in Scilit: